ORIONINFU fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Orion Infusions Ltd. engages in the manufacture of Large Volume Parenteral (LVP) and other injectable products. Its products include Dextrolac, Dextropac, Dextrosal, Dianak, Electro Dex, Fructose, Hartman, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. The company was founded by Arzuda Karim and Mohammad Obaidul Karim on May 5, 1983 and is headquartered in Dhaka, Bangladesh.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
ORIONINFU does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company